An interventional study of Robot Assisted Gait Training in Physical Disability, CP (Cerebral Palsy) and Developmental Disability, sponsored by University of Calgary. Recruiting at 1 site in Canada. Open to participants aged 4 Years and older. Per ClinicalTrials.gov, last updated 2026-02-06.
Sponsored by University of Calgary · Not applicable, Interventional, and Other
Among 11 studies in Cerebral Palsy by University of Calgary — 4 open to participants now, 4 under way, none of them phase 3. Cerebral Palsy · University of Calgary.
Among the 11 studies in Cerebral Palsy by University of Calgary, this one is the 2nd largest by planned enrollment of the 10 interventional ones, is one of 3 that started in 2022, is one of 6 with no phase, and was the 6th registered.
1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.
This study's planned enrollment of 50 is above the median of 34 across 1,431 interventional studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →4 of the 11 studies in Cerebral Palsy by University of Calgary are open now, in 1 country. Each count lists the studies.
Of the 270 Cerebral Palsy studies recruiting now, 27 (10%) set no upper age limit and 235 (87%) stop at 75 or younger; 255 take children under 18; 51 take healthy volunteers.
This study: 4 Years and older · all sexes · no healthy volunteers.
The full table on the hub →11 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 3 started in 2022.
Median enrollment 22 across the 10 interventional studies, 1 across the 1 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
University of Calgary is the lead sponsor of 703 studies on the registry; 196 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.
2 of the studies in Cerebral Palsy by University of Calgary that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06407219University of CalgaryEvaluating the Impacts of a Single Session of Robot Assisted Gait Training With a Trexo | 2026-12 |
| NCT07073378University of CalgaryBCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities | 2027-08-31 |
Among the 11 studies in Cerebral Palsy by University of Calgary, from their registry updates:
Nothing recorded among them since 2026-09-25.
Early use of robotic gait trainers have shown many benefits, however why these benefits occur and how to maximize them is unknown. There are a few options for how a robotic gait trainer can be used, however, there is not much understanding of how these options impact rehabilitation and compensate for impairments. The investigators aim to evaluate the impacts of as single session of Trexo robotic gait training and the impact of different modes of the Trexo robotic gait trainer. The investigators will evaluate how the different settings impact things like physical activity, walking, brain activity, spasticity, and fatigue. Investigators will arrange for a familiarity and fitting session to start, so that study team members can fit the participant to the Trexo and so that participants can become familiar with the feeling of using the Trexo robotic gait trainer. After the initial fitting sessions, follow up sessions will be completed to evaluate different settings on the Trexo, for example in "endurance" mode (where the robot completes the movements for the participant) and in "strength" mode (where the robot requires some assistance from the participant). Investigators may also test different fitting settings, for example with and without the supportive seat in the Trexo. Only three visits are required (one fitting/familiarity session and two testing sessions), however participants and/or their families may choose to complete more testing sessions if they want to assess other aspects of the training. For example, if the first two testing sessions assessed physical activity, participants and their families may choose to return for further sessions to assess brain activity. The aim of the study is to determine how robot assisted gait training impacts rehabilitation and compensates for impairments, as well as to provide suggestions on how the robotic gait trainer might be improved or modified. This study is exploratory to find out more about how these robotic gait trainers, specifically the Trexo, impacts various aspects of rehabilitation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will complete a training session using the Trexo robotic gait trainer in the "endurance" mode with a fixed gait pattern regardless of the participant's activity.
Device: Robot Assisted Gait Training
Participants will complete a training session using the Trexo robotic gait trainer in the "strength" mode where the gait pattern is impacted by the participant's activity
Device: Robot Assisted Gait Training
The Trexo robotic gait trainer will be used to facilitate physical activity in people who cannot walk independently, either at all or without the use of assistive gait aids (ie. walkers or canes). Session length will be determined by the participant's perceived fatigue level (ie. the session will run until the participant feels they want to or need to stop), and will not exceed 1 hour of training time.
Change in Heart Rate Response to Exercise
We will use the collected heart rate as well as an estimated maximum heart rate (208-0.7\*age) to determine the heart rate reserve (estimated maximum heart rate minus measured resting heart rate). Once the heart rate reserve has been calculated, the measured heart rate throughout the session will be used to determine how much time the participant spent above 40% of their heart rate reserve.
Time frame: Through study completion, an average of 4 weeks.
Duration of Exercise Session
Total time participant spends actively using the Trexo. This is measured directly using the Trexo Robotics application.
Time frame: Through study completion, an average of 4 weeks.
Total Number of Steps Taken
Total number of steps that the participant takes in the robotic gait trainer for the duration of the session. This is measured directly in the Trexo Robotics application.
Time frame: Through study completion, an average of 4 weeks.
Average Number of Steps per Minute
Average number of steps taken per minute while actively using the Trexo. This is measured directly in the Trexo Robotics application.
Time frame: Through study completion, an average of 4 weeks.
Participant or Proxy Report of Rating of Perceived Exertion (RPE)
The participant's (or proxy, if participant is unable to communicate their RPE) perceived level of exertion for the robot assisted gait training session. This will be assessed using a rating of fatigue scale (0-10).
Time frame: Through study completion, an average of 4 weeks.
Brain Region Activation
Brain region activation will be assessed using electroencephalography (EEG) or functional near infrared spectroscopy (fNIRS). Both methods require participants to wear a cap in order to record this data. There are no contraindications to EEG or fNIRS.
Time frame: Through study completion, an average of 4 weeks.
Muscle Activation
Muscle activation will be assessed using electromyography (EMG) or mechanomyography (MMG). Both methods require surface electrodes to be placed on the skin. There are no contraindications to EMG or MMG.
Time frame: Through study completion, an average of 4 weeks.
Characteristics of Gait / Walking Pattern
Assessed using inertial measurement units (IMUs) during training sessions as well as between sessions to gather data on gait patterns outside of the robotic gait trainer. IMUs will be placed on the top of each foot of the participant (2 IMUs total).
Time frame: Through study completion, an average of 4 weeks.
Leg Muscle Spasticity
Assessed using the EMG/MMG (mentioned above) and the Biodex dynamometer. Muscles to be assessed may include: quadriceps, hamstrings, and plantarflexors. The leg will be moved passively through its range of motion while muscle activation is sensed using the sensors of the EMG/MMG system.
Time frame: Through study completion, an average of 4 weeks.
Physical Activity Level
Reported physical activity levels will be assessed using the habitual activity estimation scale (HAES) for a typical weekday as well as a typical weekend day. The HAES is a participant or proxy report of physical activity levels.
Time frame: Through study completion, an average of 4 weeks.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.